Anti-EBAG9 Antibody

The polyclonal IgG reagent from Antibodies.com targets EBAG9, a Golgi-associated membrane protein also known as RCAS1 that has been implicated in tumor immune evasion and is widely studied as a biomarker in breast, ovarian, and gastric carcinoma research. Raised in rabbit, this unconjugated antibody is supplied as 200 µl of liquid and is validated for Western blot (WB) and immunohistochemistry (IHC) applications across human, mouse, and rat samples. The reagent supports detection of endogenous EBAG9 in cell lysates and in formalin-fixed paraffin-embedded tissue sections, enabling investigations of cancer cell proliferation, apoptosis modulation, and tumor microenvironment interactions. Recommended workflows include immunoblotting of whole-cell extracts to confirm the ~32 kDa EBAG9 band and chromogenic IHC on tumor biopsies to assess expression patterns linked to prognosis and immune escape mechanisms. Aliquot upon arrival and store at -20°C to preserve antibody activity across multiple experiments.